市場調査レポート
商品コード
1386356
髄膜炎菌ワクチン市場レポート:2030年までの動向、予測、競合分析Meningococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
髄膜炎菌ワクチン市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
髄膜炎菌ワクチンの動向と予測
世界の髄膜炎菌ワクチン市場は、2024年から2030年までのCAGRが8.5%で、2030年までに推定66億6,000万米ドルに達すると予想されています。この市場の主な促進要因は、髄膜炎の有病率の増加、予防接種プログラムの拡大、新ワクチンの開発の高まりです。髄膜炎菌ワクチンの世界市場の将来は、小売薬局と病院薬局市場に機会があり、有望視されています。
髄膜炎菌ワクチン市場の洞察
Lucintelは、結合型ワクチンは多糖類ワクチンよりも免疫原性が高く、反応原性が低いなどの特徴から、予測期間中に最も高い成長が見込まれると予測しています。
同市場では、病院での予防接種が多いため、病院薬局が引き続き最大セグメントとなります。
Meningococcal Vaccine Trends and Forecast
The future of the global meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets. The global meningococcal vaccine market is expected to reach an estimated $6.66 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.
A more than 150-page report is developed to help in your business decisions.
Meningococcal Vaccine by Segment
The study includes a forecast for the global meningococcal vaccine by type, end use, and region.
Meningococcal Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Meningococcal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Meningococcal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Meningococcal Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies meningococcal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the meningococcal vaccine companies profiled in this report include-
Meningococcal Vaccine Market Insights
Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.
Within this market, hospital pharmacy will remain the largest segment due to the high volume of vaccinations administered in this facility.
Features of the Global Meningococcal Vaccine Market
Market Size Estimates: Meningococcal vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Meningococcal vaccine market size by type, end use, and region in terms of value ($B).
Regional Analysis: Meningococcal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the meningococcal vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the meningococcal vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the meningococcal vaccine market size?
Answer: The global meningococcal vaccine market is expected to reach an estimated 6.66 billion by 2030.
Q.2 What is the growth forecast for meningococcal vaccine market?
Answer: The global meningococcal vaccine market is expected to grow with a CAGR of 8.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the meningococcal vaccine market?
Answer: The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.
Q4. What are the major segments for meningococcal vaccine market?
Answer: The future of the meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets.
Q5. Who are the key meningococcal vaccine market companies?
Answer: Some of the key meningococcal vaccine companies are as follows:
Q6. Which meningococcal vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.
Q7. In meningococcal vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of meningococcal disease among adolescents and young adults in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.